Advertisement

Special Ancillary Techniques: Immunohistochemistry

  • Gary Tse
  • Puay Hoon Tan
  • Fernando Schmitt
Chapter

Abstract

The role of immunohistochemistry in the assessment of breast lesions, in particular breast cancers, cannot be overemphasized. Currently, there is a whole gamut of markers that are being used, aiding in the differentiation between benign and malignant breast lesions, prognostication of breast cancers, and prediction of responses to therapy. While most of the routine immunohistochemistry studies are being done on the paraffin-embedded histologic samples using either the resection specimen or the preoperative biopsy, the use of cytologic preparations in immunohistochemistry is gaining popularity and experience.

Keywords

Breast Cancer Breast Lesion Myoepithelial Cell Lobular Carcinoma Invasive Lobular Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aiad HA, Abd El-Halim Kandil M, Abd El-Wahed MM et al (2011) Diagnostic role of p63 immunostaining in fine needle aspiration cytology of different breast lesions. Acta Cytol 55:149–157PubMedCrossRefGoogle Scholar
  2. Becette V, Lerebours F, Spyratos F et al (2011) Cell immunomarker studies of fine-needle cytopuncture blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma. Breast J 17:121–128PubMedCrossRefGoogle Scholar
  3. Briffod M, Hacène K, Le Doussal V (2000) Immu­nohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases. Mod Pathol 13:841–850PubMedCrossRefGoogle Scholar
  4. Cano G, Milanezi F, Leitão D et al (2003) Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol 29:207–211PubMedCrossRefGoogle Scholar
  5. Colecchia M, Frigo B, Zucchi A et al (1995) p53 protein expression in fine-needle aspirates of breast cancer: an immunocytochemical assay for identifying high-grade ductal carcinomas. Diagn Cytopathol 13:128–132PubMedCrossRefGoogle Scholar
  6. Corkill ME, Katz R (1994) Immunocytochemical staining of c-erb B-2 oncogene in fine-needle aspirates of breast carcinoma: a comparison with tissue sections and other breast cancer prognostic factors. Diagn Cytopathol 11:250–254PubMedCrossRefGoogle Scholar
  7. Dalquen P, Baschiera B, Chaffard R et al (1997) MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears. Acta Cytol 41:229–237PubMedCrossRefGoogle Scholar
  8. Delgallo WD, Rodrigues JR, Bueno SP et al (2010) Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma. Cytopathology 21:259–266PubMedCrossRefGoogle Scholar
  9. Dowsett M, Nielsen TO, A’Herm R et al (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103:1656–1664PubMedCrossRefGoogle Scholar
  10. Gusterson BA, Gullick WJ, Venter DJ et al (1988) Immunohistochemical localization of c-erbB-2 in human breast carcinomas. Mol Cell Probes 2:383–391Google Scholar
  11. Hanley KZ, Birdsong GG, Cohen C et al (2009) Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer 117:279–288PubMedGoogle Scholar
  12. Harton AM, Wang HH, Schnitt SJ et al (2007) p63 immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast. Am J Clin Pathol 128:80–85PubMedCrossRefGoogle Scholar
  13. Jares P, Rey MJ, Fernández PL et al (1997) Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol 182:160–166PubMedCrossRefGoogle Scholar
  14. Jayaram G, Elsayed EM (2005) Cytologic evaluation of prognostic markers in breast carcinoma. Acta Cytol 49:605–610PubMedCrossRefGoogle Scholar
  15. Jorda M, Ganjei P, Nadji M (1994) Retrospective c-erbB-2 immunostaining in aspiration cytology of breast cancer. Diagn Cytopathol 11:262–265PubMedCrossRefGoogle Scholar
  16. Kalogeraki A, Garbagnati F, Santinami M et al (2003) E-cadherin expression on fine needle aspiration biopsies of breast invasive ductal carcinomas and its relationship to clinicopathologic factors. Acta Cytol 47:363–367PubMedCrossRefGoogle Scholar
  17. Klorin G, Keren R (2003) Prognostic markers in histologic and cytologic specimens of breast cancer. Anal Quant Cytol Histol 25:297–302PubMedGoogle Scholar
  18. Koutselini H, Malliri A, Field JK et al (1991) p53 expression in cytologic specimens from benign and malignant breast lesions. Anticancer Res 11:1415–1420PubMedGoogle Scholar
  19. Lofgren L, Skoog L, von Schoultz E et al (2003) Hormone receptor status in breast cancer--a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 14:136–142PubMedCrossRefGoogle Scholar
  20. Makris A, Allred DC, Powles TJ et al (1997) Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Res Treat 44:65–74PubMedCrossRefGoogle Scholar
  21. Marrazzo A, Taormina P, Leonardi P et al (1995) Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study. Anticancer Res 15:521–526PubMedGoogle Scholar
  22. Midulla C, Pisani T, De Lorio P et al (2002) Cytological analysis and immunocytochemical expression of Ki67 and Bcl-2 in breast proliferative lesions. Anticancer Res 22:1341–1345PubMedGoogle Scholar
  23. Moriki T, Takahashi T, Ueta S et al (2004) Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls. Diagn Cytopathol 30:251–256PubMedCrossRefGoogle Scholar
  24. Nizzoli R, Bozzetti C, Savoldi L et al (1994) Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Acta Cytol 38:933–938PubMedGoogle Scholar
  25. Nizzoli R, Bozzetti C, Naldi N et al (2000) Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas. Cancer 90:61–66PubMedCrossRefGoogle Scholar
  26. Nizzoli R, Bozzetti C, Crafa P et al (2003) Immuno­cytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas. Diagn Cytopathol 28:142–146PubMedCrossRefGoogle Scholar
  27. Ostrowski ML, Pindur L, Laucirica R et al (2001) Proliferative activity in invasive breast carcinoma: a comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to image analytic, flow cytometric and histologic parameters. Acta Cytol 45:965–972PubMedCrossRefGoogle Scholar
  28. Park K, Han S, Kim HY et al (2001) Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer 93:211–215PubMedCrossRefGoogle Scholar
  29. Pelosi G, Bresaola E, Rodella S et al (1994) Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: an immunochemical study with clinical, pathobiological, and histologic correlations. Diagn Cytopathol 11:131–140PubMedCrossRefGoogle Scholar
  30. Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRefGoogle Scholar
  31. Railo M, Nordling S, Krogerus L et al (1996) Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagn Cytopathol 15:205–210PubMedCrossRefGoogle Scholar
  32. Reiner A, Reiner G, Spona J et al (1987) Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer. Am J Clin Pathol 88:399–404PubMedGoogle Scholar
  33. Reis-Filho JS, Milanezi F, Amendoeira I et al (2002) p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol 55:936–939PubMedCrossRefGoogle Scholar
  34. Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 23(Suppl 2):S60–S64PubMedCrossRefGoogle Scholar
  35. Shabaik A, Lin G, Peterson M et al (2011) Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagn Cytopathol 39:328–332PubMedCrossRefGoogle Scholar
  36. Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712PubMedCrossRefGoogle Scholar
  37. Stephenson TJ, Royds JA, Silcocks PB et al (1994) Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast. Cytopathology 5:146–153PubMedCrossRefGoogle Scholar
  38. Tafjord S, Bøhler PJ, Risberg B et al (2002) Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol 26:137–141PubMedCrossRefGoogle Scholar
  39. Williams SL, Birdsong GG, Cohen C et al (2009) Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations. Int J Clin Exp Pathol 2:476–480PubMedGoogle Scholar
  40. Zoppi J, Rotundo AV, Sundblad AS (2002) Correlation of immunocytochemical and immunohistochemical determination of estrogen and progesterone receptors in breast cancer. Acta Cytol 46:337–340PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Gary Tse
    • 1
  • Puay Hoon Tan
    • 2
  • Fernando Schmitt
    • 3
  1. 1.Prince of Wales Hospital Department of Anatomical And Cellular PathologyThe Chinese University of Hong KongShatin, NTHong Kong SAR
  2. 2.Department of PathologySingapore General HospitalSingaporeSingapore
  3. 3.Department of Pathology and OncologyMedical Faculty of Porto University and IPATIMUPPortoPortugal

Personalised recommendations